1
ASCENDIS PHARMA A/S
ORD SHS
ASND
ASND
233,171
$62.2m5.40%
5.40%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 233.2k
2
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
219,596
$53.8m4.67%
4.67%
Reduced Shares held: Q3 2025 530.3k, Q4 2025 251.6k, Q1 2026 264.3k, Q2 2026 219.6k
-44.7k
-44,708
-16.9%
3
ELI LILLY & CO
COM
LLY
LLY
39,258
$47.1m4.09%
4.09%
Reduced Shares held: Q3 2025 225.1k, Q4 2025 68.3k, Q1 2026 65.8k, Q2 2026 39.3k
-26.5k
-26,504
-40.3%
4
JAZZ PHARMACEUTICALS PLC
SHS USD
JAZZ
JAZZ
160,768
$38.7m3.36%
3.36%
Reduced Shares held: Q3 2025 0, Q4 2025 50.5k, Q1 2026 178.1k, Q2 2026 160.8k
-17.4k
-17,376
-9.8%
5
HUMANA INC
COM
HUM
HUM
94,375
$37.5m3.25%
3.25%
New Shares held: Q3 2025 3.6k, Q4 2025 0, Q1 2026 0, Q2 2026 94.4k
6
UNITEDHEALTH GROUP INC
COM
UNH
UNH
88,276
$36.7m3.19%
3.19%
Added Shares held: Q3 2025 0, Q4 2025 50.5k, Q1 2026 58.0k, Q2 2026 88.3k
+30.2k
+30,238
52.1%
7
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
213,407
$36.0m3.12%
3.12%
Reduced Shares held: Q3 2025 57.2k, Q4 2025 163.2k, Q1 2026 215.7k, Q2 2026 213.4k
-2.3k
-2,271
-1.1%
8
INHIBRX BIOSCIENCES INC
COM
INBX
INBX
308,385
$29.2m2.54%
2.54%
Added Shares held: Q3 2025 239.6k, Q4 2025 265.5k, Q1 2026 305.4k, Q2 2026 308.4k
+3.0k
+2,954
1.0%
9
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
49,991
$27.1m2.35%
2.35%
Added Shares held: Q3 2025 95.7k, Q4 2025 67.7k, Q1 2026 39.8k, Q2 2026 50.0k
+10.2k
+10,186
25.6%
10
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
143,222
$26.8m2.33%
2.33%
Added Shares held: Q3 2025 331.1k, Q4 2025 151.5k, Q1 2026 140.8k, Q2 2026 143.2k
+2.5k
+2,452
1.7%
11
ICON PLC
SHS
ICLR
ICLR
136,482
$23.7m2.06%
2.06%
Added Shares held: Q3 2025 133.7k, Q4 2025 115.3k, Q1 2026 57.5k, Q2 2026 136.5k
+79.0k
+78,982
137.4%
12
TENET HEALTHCARE CORP
COM NEW
THC
THC
126,572
$23.7m2.06%
2.06%
Reduced Shares held: Q3 2025 461.7k, Q4 2025 397.8k, Q1 2026 398.6k, Q2 2026 126.6k
-272.0k
-271,995
-68.2%
13
EDWARDS LIFESCIENCES CORP
COM
EW
EW
250,453
$22.7m1.97%
1.97%
Reduced Shares held: Q3 2025 381.3k, Q4 2025 246.8k, Q1 2026 254.5k, Q2 2026 250.5k
-4.1k
-4,057
-1.6%
14
WATERS CORP
COM
WAT
WAT
59,825
$22.4m1.95%
1.95%
Added Shares held: Q3 2025 30.8k, Q4 2025 43.2k, Q1 2026 39.8k, Q2 2026 59.8k
+20.1k
+20,062
50.5%
15
PENUMBRA INC
COM
PEN
PEN
60,221
$19.0m1.65%
1.65%
Reduced Shares held: Q3 2025 195.1k, Q4 2025 145.2k, Q1 2026 139.8k, Q2 2026 60.2k
-79.6k
-79,558
-56.9%
16
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
253,358
$18.9m1.64%
1.64%
Reduced Shares held: Q3 2025 327.2k, Q4 2025 306.5k, Q1 2026 257.7k, Q2 2026 253.4k
-4.4k
-4,389
-1.7%
17
STRYKER CORPORATION
COM
SYK
SYK
56,637
$17.8m1.55%
1.55%
Added Shares held: Q3 2025 0, Q4 2025 50.9k, Q1 2026 22.0k, Q2 2026 56.6k
+34.7k
+34,680
157.9%
18
METTLER TOLEDO INTERNATIONAL
COM
MTD
MTD
13,344
$17.0m1.48%
1.48%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 13.3k
19
INDIVIOR PHARMACEUTICALS INC
COM
INDV
INDV
401,208
$16.5m1.43%
1.43%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 574.7k, Q2 2026 401.2k
-173.5k
-173,458
-30.2%
20
MERCK & CO INC
COM
MRK
MRK
127,118
$16.3m1.42%
1.42%
New Shares held: Q3 2025 236.5k, Q4 2025 187.8k, Q1 2026 0, Q2 2026 127.1k
21
CYTOKINETICS INC
COM NEW
CYTK
CYTK
191,686
$16.3m1.42%
1.42%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 191.7k
22
LANTHEUS HLDGS INC
COM
LNTH
LNTH
146,403
$16.2m1.41%
1.41%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 146.4k
23
CENTENE CORP DEL
COM
CNC
CNC
248,867
$16.0m1.39%
1.39%
Reduced Shares held: Q3 2025 574.4k, Q4 2025 725.4k, Q1 2026 263.5k, Q2 2026 248.9k
-14.6k
-14,619
-5.5%
24
COOPER COS INC
COM
COO
COO
220,890
$15.8m1.38%
1.38%
Added Shares held: Q3 2025 74.4k, Q4 2025 100.8k, Q1 2026 169.8k, Q2 2026 220.9k
+51.1k
+51,061
30.1%
25
MADRIGAL PHARMACEUTICALS INC
COM
MDGL
MDGL
29,313
$15.7m1.37%
1.37%
Reduced Shares held: Q3 2025 0, Q4 2025 7.3k, Q1 2026 34.1k, Q2 2026 29.3k
-4.8k
-4,833
-14.2%
26
ACADIA HEALTHCARE COMPANY IN
COM
ACHC
ACHC
524,934
$15.5m1.35%
1.35%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 582.7k, Q2 2026 524.9k
-57.8k
-57,811
-9.9%
27
ORUKA THERAPEUTICS INC
COM
ORKA
ORKA
158,825
$15.1m1.31%
1.31%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 174.1k, Q2 2026 158.8k
-15.2k
-15,227
-8.8%
28
OSCAR HEALTH INC
CL A
OSCR
OSCR
519,016
$14.8m1.29%
1.29%
Added Shares held: Q3 2025 820.6k, Q4 2025 499.8k, Q1 2026 499.8k, Q2 2026 519.0k
+19.2k
+19,179
3.8%
29
THERMO FISHER SCIENTIFIC INC
COM
TMO
TMO
28,496
$14.3m1.24%
1.24%
Added Shares held: Q3 2025 2.3k, Q4 2025 37.9k, Q1 2026 14.8k, Q2 2026 28.5k
+13.7k
+13,664
92.1%
30
CVS HEALTH CORP
COM
CVS
CVS
137,457
$14.2m1.23%
1.23%
New Shares held: Q3 2025 346.7k, Q4 2025 107.8k, Q1 2026 0, Q2 2026 137.5k
31
MERIT MED SYS INC
COM
MMSI
MMSI
197,038
$13.7m1.19%
1.19%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 162.5k, Q2 2026 197.0k
+34.6k
+34,569
21.3%
32
PRAXIS PRECISION MEDICINES I
COM NEW
PRAX
PRAX
38,575
$12.9m1.12%
1.12%
Added Shares held: Q3 2025 60.6k, Q4 2025 31.2k, Q1 2026 35.4k, Q2 2026 38.6k
+3.1k
+3,137
8.8%
33
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
342,751
$12.8m1.11%
1.11%
Added Shares held: Q3 2025 0, Q4 2025 133.2k, Q1 2026 325.0k, Q2 2026 342.8k
+17.8k
+17,794
5.5%
34
NOVO-NORDISK A S
ADR
NVO
NVO
265,016
$12.7m1.10%
1.10%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 197.2k, Q2 2026 265.0k
+67.8k
+67,835
34.4%
35
INTEGER HLDGS CORP
COM
ITGR
ITGR
126,669
$11.8m1.03%
1.03%
Reduced Shares held: Q3 2025 0, Q4 2025 106.6k, Q1 2026 135.1k, Q2 2026 126.7k
-8.4k
-8,412
-6.2%
36
DIANTHUS THERAPEUTICS INC
COM
DNTH
DNTH
121,222
$11.8m1.03%
1.03%
Reduced Shares held: Q3 2025 67.8k, Q4 2025 99.6k, Q1 2026 172.1k, Q2 2026 121.2k
-50.9k
-50,915
-29.6%
37
DEFINIUM THERAPEUTICS INC
COM SHS
DFTX
DFTX
249,020
$11.7m1.02%
1.02%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 205.3k, Q2 2026 249.0k
+43.7k
+43,703
21.3%
38
GILEAD SCIENCES INC
COM
GILD
GILD
90,858
$11.5m1.00%
1.00%
New Shares held: Q3 2025 0, Q4 2025 71.0k, Q1 2026 0, Q2 2026 90.9k
39
RHYTHM PHARMACEUTICALS INC
COM
RYTM
RYTM
101,550
$11.3m0.98%
0.98%
Reduced Shares held: Q3 2025 48.2k, Q4 2025 40.2k, Q1 2026 136.6k, Q2 2026 101.5k
-35.1k
-35,071
-25.7%
40
HENRY SCHEIN INC
COM
HSIC
HSIC
134,423
$11.2m0.97%
0.97%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 153.1k, Q2 2026 134.4k
-18.7k
-18,691
-12.2%
41
ARROWHEAD PHARMACEUTICALS IN
COM
ARWR
ARWR
131,667
$10.7m0.93%
0.93%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 64.3k, Q2 2026 131.7k
+67.4k
+67,388
104.8%
42
TANGO THERAPEUTICS INC
COM
TNGX
TNGX
326,047
$10.2m0.88%
0.88%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 406.2k, Q2 2026 326.0k
-80.2k
-80,198
-19.7%
43
TELEFLEX INCORPORATED
COM
TFX
TFX
79,708
$10.1m0.88%
0.88%
New Shares held: Q3 2025 0, Q4 2025 102.4k, Q1 2026 0, Q2 2026 79.7k
44
VIKING THERAPEUTICS INC
COM
VKTX
VKTX
255,330
$10.0m0.86%
0.86%
Reduced Shares held: Q3 2025 183.5k, Q4 2025 189.0k, Q1 2026 263.1k, Q2 2026 255.3k
-7.8k
-7,776
-3.0%
45
BRIGHTSPRING HEALTH SVCS INC
COM
BTSG
BTSG
141,914
$9.9m0.86%
0.86%
Reduced Shares held: Q3 2025 0, Q4 2025 118.5k, Q1 2026 187.3k, Q2 2026 141.9k
-45.4k
-45,421
-24.2%
46
VERA THERAPEUTICS INC
CL A
VERA
VERA
224,289
$9.6m0.84%
0.84%
Added Shares held: Q3 2025 513.7k, Q4 2025 107.7k, Q1 2026 174.9k, Q2 2026 224.3k
+49.4k
+49,422
28.3%
47
ROIVANT SCIENCES LTD
SHS
ROIV
ROIV
268,008
$9.5m0.82%
0.82%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 207.4k, Q2 2026 268.0k
+60.6k
+60,562
29.2%
48
CG ONCOLOGY INC
COM
CGON
CGON
128,286
$9.1m0.79%
0.79%
Reduced Shares held: Q3 2025 157.9k, Q4 2025 164.0k, Q1 2026 165.9k, Q2 2026 128.3k
-37.6k
-37,639
-22.7%
49
AMNEAL PHARMACEUTICALS INC
COM STK CL A
AMRX
AMRX
480,715
$8.3m0.72%
0.72%
Reduced Shares held: Q3 2025 355.8k, Q4 2025 1.5m, Q1 2026 930.1k, Q2 2026 480.7k
-449.4k
-449,381
-48.3%
50
EUPRAXIA PHARMACEUTICALS INC
COM
EPRX
EPRX
1,210,661
$8.0m0.69%
0.69%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 540.9k, Q2 2026 1.2m
+669.8k
+669,790
123.8%
51
IRHYTHM TECHNOLOGIES INC
COM
IRTC
IRTC
65,196
$7.8m0.67%
0.67%
New Shares held: Q3 2025 65.0k, Q4 2025 0, Q1 2026 0, Q2 2026 65.2k
52
KODIAK SCIENCES INC
COM
KOD
KOD
193,315
$7.5m0.65%
0.65%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 114.7k, Q2 2026 193.3k
+78.6k
+78,596
68.5%
53
ABBOTT LABS
COM
ABT
ABT
82,230
$7.5m0.65%
0.65%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 140.4k, Q2 2026 82.2k
-58.2k
-58,202
-41.4%
54
WEST PHARMACEUTICAL SVSC INC
COM
WST
WST
20,733
$7.4m0.65%
0.65%
New Shares held: Q3 2025 18.4k, Q4 2025 0, Q1 2026 0, Q2 2026 20.7k
55
TAKEDA PHARMACEUTICAL CO LTD
SPONSORED ADS
TAK
TAK
444,173
$7.1m0.62%
0.62%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 444.2k
56
HINGE HEALTH INC
CL A
HNGE
HNGE
82,860
$6.9m0.60%
0.60%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 82.9k
57
ARCUTIS BIOTHERAPEUTICS INC
COM
ARQT
ARQT
242,069
$6.3m0.55%
0.55%
New Shares held: Q3 2025 360.5k, Q4 2025 0, Q1 2026 0, Q2 2026 242.1k
58
INTEGRA LIFESCIENCES HLDGS C
COM NEW
IART
IART
348,746
$6.3m0.54%
0.54%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 348.7k
59
ILLUMINA INC
COM
ILMN
ILMN
35,040
$6.2m0.53%
0.53%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 28.9k, Q2 2026 35.0k
+6.2k
+6,171
21.4%
60
MEIRAGTX HLDGS PLC
COM
MGTX
MGTX
455,286
$6.2m0.53%
0.53%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 455.3k
61
OCULIS HOLDING AG
ORDINARY SHARES
OCS
OCS
436,042
$6.0m0.53%
0.53%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 436.0k
62
NATERA INC
COM
NTRA
NTRA
22,077
$6.0m0.52%
0.52%
Reduced Shares held: Q3 2025 115.6k, Q4 2025 0, Q1 2026 60.0k, Q2 2026 22.1k
-37.9k
-37,927
-63.2%
63
ABIVAX SA
SPONSORED ADS
ABVX
ABVX
43,264
$5.8m0.50%
0.50%
Added Shares held: Q3 2025 0, Q4 2025 31.9k, Q1 2026 26.7k, Q2 2026 43.3k
+16.6k
+16,600
62.3%
64
GUARDANT HEALTH INC
COM
GH
GH
36,701
$5.5m0.48%
0.48%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 36.7k
65
CELCUITY INC
COM
CELC
CELC
52,155
$5.5m0.47%
0.47%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 52.2k
66
BELITE BIO INC
SPONSORED ADS
BLTE
BLTE
34,803
$5.4m0.47%
0.47%
Reduced Shares held: Q3 2025 0, Q4 2025 19.8k, Q1 2026 59.4k, Q2 2026 34.8k
-24.6k
-24,629
-41.4%
67
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
91,550
$4.9m0.43%
0.43%
Reduced Shares held: Q3 2025 115.1k, Q4 2025 68.2k, Q1 2026 126.4k, Q2 2026 91.5k
-34.8k
-34,833
-27.6%
68
ARCUS BIOSCIENCES INC
COM
RCUS
RCUS
152,129
$4.7m0.41%
0.41%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 152.1k
69
CHARLES RIV LABS INTL INC
COM
CRL
CRL
18,747
$4.3m0.37%
0.37%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 18.7k
70
ELANCO ANIMAL HEALTH INC
COM
ELAN
ELAN
172,489
$4.2m0.37%
0.37%
New Shares held: Q3 2025 0, Q4 2025 207.3k, Q1 2026 0, Q2 2026 172.5k
71
ARGENX SE
SPONSORED ADR
ARGX
ARGX
4,482
$4.2m0.36%
0.36%
Reduced Shares held: Q3 2025 6.4k, Q4 2025 4.2k, Q1 2026 4.5k, Q2 2026 4.5k
-53
-53
-1.2%
72
BIO RAD LABS INC
CL A
BIO
BIO
13,995
$4.1m0.36%
0.36%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 14.0k
73
SPYRE THERAPEUTICS INC
COM NEW
SYRE
SYRE
46,217
$4.1m0.36%
0.36%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 46.2k
74
MBX BIOSCIENCES INC
COM
MBX
MBX
70,971
$3.9m0.34%
0.34%
Reduced Shares held: Q3 2025 221.5k, Q4 2025 79.3k, Q1 2026 71.9k, Q2 2026 71.0k
-923
-923
-1.3%
75
MIRUM PHARMACEUTICALS INC
COM
MIRM
MIRM
31,536
$3.7m0.32%
0.32%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 31.5k
76
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
192,442
$3.5m0.30%
0.30%
Reduced Shares held: Q3 2025 0, Q4 2025 227.0k, Q1 2026 227.4k, Q2 2026 192.4k
-35.0k
-34,964
-15.4%
77
COMPASS PATHWAYS PLC
SPONSORED ADS
CMPS
CMPS
247,589
$3.5m0.30%
0.30%
Reduced Shares held: Q3 2025 1.7m, Q4 2025 779.6k, Q1 2026 1.4m, Q2 2026 247.6k
-1.1m
-1,119,510
-81.9%
78
HCA HEALTHCARE INC
COM
HCA
HCA
8,295
$3.2m0.28%
0.28%
Reduced Shares held: Q3 2025 65.8k, Q4 2025 13.9k, Q1 2026 13.4k, Q2 2026 8.3k
-5.1k
-5,056
-37.9%
79
CAPRICOR THERAPEUTICS INC
COM NEW
CAPR
CAPR
122,221
$2.9m0.26%
0.26%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 123.8k, Q2 2026 122.2k
-1.6k
-1,610
-1.3%
80
DENALI THERAPEUTICS INC
COM
DNLI
DNLI
100,966
$2.6m0.23%
0.23%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 101.0k
81
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
118,422
$2.6m0.22%
0.22%
Reduced Shares held: Q3 2025 256.5k, Q4 2025 243.0k, Q1 2026 245.0k, Q2 2026 118.4k
-126.6k
-126,599
-51.7%
82
AMYLYX PHARMACEUTICALS INC
COM
AMLX
AMLX
143,700
$2.6m0.22%
0.22%
Reduced Shares held: Q3 2025 436.2k, Q4 2025 134.5k, Q1 2026 145.3k, Q2 2026 143.7k
-1.6k
-1,575
-1.1%
83
TARSUS PHARMACEUTICALS INC
COM
TARS
TARS
40,579
$2.6m0.22%
0.22%
Reduced Shares held: Q3 2025 0, Q4 2025 27.3k, Q1 2026 80.2k, Q2 2026 40.6k
-39.6k
-39,647
-49.4%
84
OUTSET MED INC
COM NEW
OM
OM
582,122
$2.5m0.22%
0.22%
Reduced Shares held: Q3 2025 1.7m, Q4 2025 530.8k, Q1 2026 594.6k, Q2 2026 582.1k
-12.5k
-12,508
-2.1%
85
OMADA HEALTH INC
COM
OMDA
OMDA
114,442
$2.5m0.22%
0.22%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 114.4k
86
ERASCA INC
COM
ERAS
ERAS
134,088
$2.5m0.21%
0.21%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 134.1k
87
CENCORA INC
COM
COR
COR
7,385
$2.1m0.18%
0.18%
New Shares held: Q3 2025 80.5k, Q4 2025 0, Q1 2026 0, Q2 2026 7.4k
88
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
207,357
$2.1m0.18%
0.18%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 207.4k
89
OMNICELL COM
COM
OMCL
OMCL
49,040
$2.0m0.18%
0.18%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 49.0k
90
CVRX INC
COM
CVRX
CVRX
369,572
$1.9m0.16%
0.16%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 369.6k
91
HIMS & HERS HEALTH INC
COM CL A
HIMS
HIMS
49,454
$1.7m0.15%
0.15%
New Shares held: Q3 2025 22.9k, Q4 2025 0, Q1 2026 0, Q2 2026 49.5k
92
MINERALYS THERAPEUTICS INC
COM
MLYS
MLYS
62,418
$1.7m0.15%
0.15%
Reduced Shares held: Q3 2025 0, Q4 2025 47.6k, Q1 2026 142.7k, Q2 2026 62.4k
-80.3k
-80,259
-56.2%
93
TECTONIC THERAPEUTIC INC
COM
TECX
TECX
45,631
$1.6m0.14%
0.14%
Reduced Shares held: Q3 2025 0, Q4 2025 42.7k, Q1 2026 46.1k, Q2 2026 45.6k
-498
-498
-1.1%
94
UNIQURE NV
SHS
QURE
QURE
26,396
$1.2m0.11%
0.11%
Reduced Shares held: Q3 2025 46.4k, Q4 2025 39.5k, Q1 2026 42.6k, Q2 2026 26.4k
-16.2k
-16,239
-38.1%
95
REZOLUTE INC
COM NEW
RZLT
RZLT
127,289
$661.9k0.06%
0.06%
Reduced Shares held: Q3 2025 452.7k, Q4 2025 206.3k, Q1 2026 128.7k, Q2 2026 127.3k
-1.4k
-1,437
-1.1%
96
CARIBOU BIOSCIENCES INC
COM
CRBU
CRBU
354,687
$624.2k0.05%
0.05%
Reduced Shares held: Q3 2025 1.4m, Q4 2025 957.8k, Q1 2026 957.8k, Q2 2026 354.7k
-603.1k
-603,100
-63.0%